Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026
Rapid diagnostic test-based algorithms for Chagas disease diagnosis: a cost-utility and budget impact analysis in Colombia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Olivera Mario J
Аннотация
BACKGROUND: Chagas disease remains underdiagnosed in endemic countries due to reliance on centralized laboratory-based algorithms. Rapid diagnostic tests (RDTs) may simplify diagnostic processes and expand access to decentralized testing, but uncertainty remains regarding their performance across heterogeneous settings and long-term economic value. This study evaluated the cost-utility and budget impact of RDT-based diagnostic strategies in Colombia.
METHODS: A cost-utility analysis was conducted from the Colombian health system perspective using a hybrid decision tree-Markov model. Three diagnostic strategies were compared: serial RDT with ELISA resolution, hybrid RDT-ELISA and the conventional ELISA algorithm with indirect immunofluorescence assay resolution. Lifetime costs and quality-adjusted life years (QALYs) were estimated. The model incorporated loss to follow-up between steps. Scenario analyses explored correlated test performance and earlier diagnosis among women of reproductive age. A 5-year budget impact analysis was conducted.
RESULTS: Lifetime costs were US$319.27, US$266.03 and US$252.74, with corresponding QALYs of 12.30, 12.34 and 12.35 for the conventional, hybrid and serial RDT strategies, respectively. Both RDT-based strategies were economically dominant.
CONCLUSIONS: RDT-based algorithms may improve access to diagnosis and reduce program costs. Improving completion of the diagnostic process may be a key driver of effectiveness and economic value.
METHODS: A cost-utility analysis was conducted from the Colombian health system perspective using a hybrid decision tree-Markov model. Three diagnostic strategies were compared: serial RDT with ELISA resolution, hybrid RDT-ELISA and the conventional ELISA algorithm with indirect immunofluorescence assay resolution. Lifetime costs and quality-adjusted life years (QALYs) were estimated. The model incorporated loss to follow-up between steps. Scenario analyses explored correlated test performance and earlier diagnosis among women of reproductive age. A 5-year budget impact analysis was conducted.
RESULTS: Lifetime costs were US$319.27, US$266.03 and US$252.74, with corresponding QALYs of 12.30, 12.34 and 12.35 for the conventional, hybrid and serial RDT strategies, respectively. Both RDT-based strategies were economically dominant.
CONCLUSIONS: RDT-based algorithms may improve access to diagnosis and reduce program costs. Improving completion of the diagnostic process may be a key driver of effectiveness and economic value.